Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.01
COO's Cash to Debt is ranked lower than
58% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. COO: 0.01 )
COO' s 10-Year Cash to Debt Range
Min: 0   Max: 1.92
Current: 0.01

0
1.92
Equity to Asset 0.58
COO's Equity to Asset is ranked higher than
70% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.57 vs. COO: 0.58 )
COO' s 10-Year Equity to Asset Range
Min: -0.03   Max: 0.8
Current: 0.58

-0.03
0.8
Interest Coverage 38.48
COO's Interest Coverage is ranked higher than
69% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.94 vs. COO: 38.48 )
COO' s 10-Year Interest Coverage Range
Min: 1.07   Max: 38.48
Current: 38.48

1.07
38.48
F-Score: 4
Z-Score: 4.13
M-Score: -2.85
WACC vs ROIC
2.76%
8.45%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 16.95
COO's Operating margin (%) is ranked higher than
89% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.43 vs. COO: 16.95 )
COO' s 10-Year Operating margin (%) Range
Min: 4.82   Max: 23.82
Current: 16.95

4.82
23.82
Net-margin (%) 14.74
COO's Net-margin (%) is ranked higher than
91% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. COO: 14.74 )
COO' s 10-Year Net-margin (%) Range
Min: -1.18   Max: 34.8
Current: 14.74

-1.18
34.8
ROE (%) 10.20
COO's ROE (%) is ranked higher than
78% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. COO: 10.20 )
COO' s 10-Year ROE (%) Range
Min: -0.79   Max: 244.12
Current: 10.2

-0.79
244.12
ROA (%) 7.01
COO's ROA (%) is ranked higher than
83% of the 313 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. COO: 7.01 )
COO' s 10-Year ROA (%) Range
Min: -0.45   Max: 22.6
Current: 7.01

-0.45
22.6
ROC (Joel Greenblatt) (%) 22.67
COO's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.59 vs. COO: 22.67 )
COO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 5.7   Max: 75.46
Current: 22.67

5.7
75.46
Revenue Growth (3Y)(%) 8.40
COO's Revenue Growth (3Y)(%) is ranked higher than
84% of the 263 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. COO: 8.40 )
COO' s 10-Year Revenue Growth (3Y)(%) Range
Min: 4.8   Max: 27.8
Current: 8.4

4.8
27.8
EBITDA Growth (3Y)(%) 12.30
COO's EBITDA Growth (3Y)(%) is ranked higher than
81% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. COO: 12.30 )
COO' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -8.6   Max: 62.2
Current: 12.3

-8.6
62.2
EPS Growth (3Y)(%) 14.90
COO's EPS Growth (3Y)(%) is ranked higher than
83% of the 229 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. COO: 14.90 )
COO' s 10-Year EPS Growth (3Y)(%) Range
Min: -15.2   Max: 474.9
Current: 14.9

-15.2
474.9
» COO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

COO Guru Trades in Q1 2014

Ron Baron 245,624 sh (New)
Manning & Napier Advisors, Inc 97,210 sh (New)
Steven Cohen 115,186 sh (+650.98%)
Paul Tudor Jones 5,907 sh (+73.43%)
Chuck Royce 3,800 sh (unchged)
Bill Frels Sold Out
Jim Simons Sold Out
Mario Gabelli 30,000 sh (-1.64%)
Ken Fisher 51,050 sh (-5.20%)
» More
Q2 2014

COO Guru Trades in Q2 2014

Mario Gabelli 49,586 sh (+65.29%)
Ron Baron 356,783 sh (+45.26%)
Manning & Napier Advisors, Inc 116,400 sh (+19.74%)
Steven Cohen 217,800 sh (unchged)
Ken Fisher 49,609 sh (-2.82%)
Chuck Royce 3,100 sh (-18.42%)
Paul Tudor Jones 4,800 sh (-18.74%)
» More
Q3 2014

COO Guru Trades in Q3 2014

Paul Tudor Jones 5,800 sh (+20.83%)
Ken Fisher 56,294 sh (+13.48%)
Steven Cohen Sold Out
Manning & Napier Advisors, Inc Sold Out
Ron Baron 356,193 sh (-0.17%)
Chuck Royce 2,200 sh (-29.03%)
Mario Gabelli 27,200 sh (-45.15%)
» More
Q4 2014

COO Guru Trades in Q4 2014

Jim Simons 223,098 sh (New)
Steve Mandel 1,750,283 sh (New)
Mario Gabelli 34,500 sh (+26.84%)
Ken Fisher 68,524 sh (+21.73%)
Chuck Royce Sold Out
Paul Tudor Jones Sold Out
Ron Baron 355,785 sh (-0.11%)
» More
» Details

Insider Trades

Latest Guru Trades with COO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Cooper Companies

Baron Funds Comments on The Cooper Companies - May 02, 2014

We established a position in The Cooper Companies, Inc. (COO) during the quarter. Cooper's primary business is manufacturing contact lenses, and it also has a relatively small unit focused on women's health products. There are several characteristics of the contact lens market that we find attractive. There are just four global players that account for the large bulk of the industry's sales, barriers to entry are high, and pricing trends are stable. The industry has grown at a mid-single digit rate for the past several years, and we believe that several developments should cause this growth rate to accelerate going forward. These include the widespread adoption of Silicon Hydrogel lenses, which provide a more comfortable user experience; recent technological advances that have led to lenses that can address a wider variety of vision deficiencies; the increasing conversion of bi-weekly contact users to daily-use lenses (which results in higher revenues for the manufacturer); and, the ongoing growth of the middle classes in emerging markets, which allows new entrants into the contact market.



Cooper is the third largest lens manufacturer with approximately 20% market share. The company has grown its share in recent years by introducing technologically superior products, particularly in the fast- growing Silicon Hydrogel market segment. We believe that Cooper can continue to grow at an above-market rate by further penetrating the global market with its superior products and by converting existing users from bi- weekly to daily contacts. In addition, we believe that Cooper should be able to expand its operating margins at a faster rate than revenues, as its Silicon Hydrogel lenses carry meaningfully higher gross margins than its legacy products, and sales growth will allow the company to leverage its fixed overheard. We believe Cooper will be able to grow its earnings per share at a high-teens rate for the next several years.



From Baron Funds' first quarter 2014 letter to investors.



Check out Ron Baron latest stock trades

Top Ranked Articles about Cooper Companies

Baron Funds Comments on The Cooper Companies
We established a position in The Cooper Companies, Inc. (COO) during the quarter. Cooper's primary business is manufacturing contact lenses, and it also has a relatively small unit focused on women's health products. There are several characteristics of the contact lens market that we find attractive. There are just four global players that account for the large bulk of the industry's sales, barriers to entry are high, and pricing trends are stable. The industry has grown at a mid-single digit rate for the past several years, and we believe that several developments should cause this growth rate to accelerate going forward. These include the widespread adoption of Silicon Hydrogel lenses, which provide a more comfortable user experience; recent technological advances that have led to lenses that can address a wider variety of vision deficiencies; the increasing conversion of bi-weekly contact users to daily-use lenses (which results in higher revenues for the manufacturer); and, the ongoing growth of the middle classes in emerging markets, which allows new entrants into the contact market. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 34.10
COO's P/E(ttm) is ranked higher than
77% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.80 vs. COO: 34.10 )
COO' s 10-Year P/E(ttm) Range
Min: 7.98   Max: 1011.75
Current: 34.1

7.98
1011.75
Forward P/E 20.49
COO's Forward P/E is ranked higher than
83% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.73 vs. COO: 20.49 )
N/A
PE(NRI) 34.20
COO's PE(NRI) is ranked higher than
80% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 58.30 vs. COO: 34.20 )
COO' s 10-Year PE(NRI) Range
Min: 8.11   Max: 2023.5
Current: 34.2

8.11
2023.5
P/B 3.50
COO's P/B is ranked higher than
64% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. COO: 3.50 )
COO' s 10-Year P/B Range
Min: 0.37   Max: 4.45
Current: 3.5

0.37
4.45
P/S 5.06
COO's P/S is ranked lower than
59% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.32 vs. COO: 5.06 )
COO' s 10-Year P/S Range
Min: 0.51   Max: 5.98
Current: 5.06

0.51
5.98
PFCF 39.80
COO's PFCF is ranked higher than
73% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 97.29 vs. COO: 39.80 )
COO' s 10-Year PFCF Range
Min: 7.34   Max: 342.65
Current: 39.8

7.34
342.65
POCF 19.04
COO's POCF is ranked higher than
82% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.60 vs. COO: 19.04 )
COO' s 10-Year POCF Range
Min: 5.51   Max: 27.33
Current: 19.04

5.51
27.33
EV-to-EBIT 34.02
COO's EV-to-EBIT is ranked higher than
76% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 36.87 vs. COO: 34.02 )
COO' s 10-Year EV-to-EBIT Range
Min: 8.2   Max: 68.2
Current: 34.02

8.2
68.2
PEG 2.69
COO's PEG is ranked higher than
92% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. COO: 2.69 )
COO' s 10-Year PEG Range
Min: 0.79   Max: 31.7
Current: 2.69

0.79
31.7
Shiller P/E 41.80
COO's Shiller P/E is ranked higher than
81% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. COO: 41.80 )
COO' s 10-Year Shiller P/E Range
Min: 6.7   Max: 49.38
Current: 41.8

6.7
49.38
Current Ratio 2.06
COO's Current Ratio is ranked higher than
65% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. COO: 2.06 )
COO' s 10-Year Current Ratio Range
Min: 0.98   Max: 3.46
Current: 2.06

0.98
3.46
Quick Ratio 1.04
COO's Quick Ratio is ranked higher than
57% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. COO: 1.04 )
COO' s 10-Year Quick Ratio Range
Min: 0.69   Max: 2.95
Current: 1.04

0.69
2.95
Days Inventory 202.38
COO's Days Inventory is ranked higher than
60% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 133.28 vs. COO: 202.38 )
COO' s 10-Year Days Inventory Range
Min: 162.06   Max: 231.4
Current: 202.38

162.06
231.4
Days Sales Outstanding 57.28
COO's Days Sales Outstanding is ranked higher than
81% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 69.74 vs. COO: 57.28 )
COO' s 10-Year Days Sales Outstanding Range
Min: 52.77   Max: 119.83
Current: 57.28

52.77
119.83

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.03
COO's Dividend Yield is ranked lower than
93% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.28 vs. COO: 0.03 )
COO' s 10-Year Dividend Yield Range
Min: 0.03   Max: 0.52
Current: 0.03

0.03
0.52
Dividend Payout 0.01
COO's Dividend Payout is ranked higher than
100% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. COO: 0.01 )
COO' s 10-Year Dividend Payout Range
Min: 0.02   Max: 0.25
Current: 0.01

0.02
0.25
Yield on cost (5-Year) 0.10
COO's Yield on cost (5-Year) is ranked lower than
87% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. COO: 0.10 )
COO' s 10-Year Yield on cost (5-Year) Range
Min: 0.04   Max: 0.33
Current: 0.1

0.04
0.33
Share Buyback Rate -0.40
COO's Share Buyback Rate is ranked higher than
83% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.00 vs. COO: -0.40 )
COO' s 10-Year Share Buyback Rate Range
Min: 1.5   Max: -13
Current: -0.4

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.90
COO's Price/DCF (Projected) is ranked higher than
84% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.80 vs. COO: 1.90 )
COO' s 10-Year Price/DCF (Projected) Range
Min: 0.55   Max: 5.86
Current: 1.9

0.55
5.86
Price/Median PS Value 1.80
COO's Price/Median PS Value is ranked higher than
58% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. COO: 1.80 )
COO' s 10-Year Price/Median PS Value Range
Min: 0.25   Max: 2.55
Current: 1.8

0.25
2.55
Price/Peter Lynch Fair Value 2.20
COO's Price/Peter Lynch Fair Value is ranked higher than
92% of the 339 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. COO: 2.20 )
COO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.6   Max: 70
Current: 2.2

0.6
70
Earnings Yield (Greenblatt) 2.90
COO's Earnings Yield (Greenblatt) is ranked higher than
70% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.20 vs. COO: 2.90 )
COO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 12.2
Current: 2.9

1.5
12.2
Forward Rate of Return (Yacktman) 17.94
COO's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.90 vs. COO: 17.94 )
COO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.4   Max: 25.9
Current: 17.94

-2.4
25.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, ISRG » details
Traded in other countries:CP6.Germany, COO.Mexico,
Cooper Companies is a Delaware corporation, which was organized on March 4, 1980. It is a medical device company. Through its subsidiaries, it manufactures products for contact lens wearers and supplies women's health clinicians with products and treatment options to improve the delivery of healthcare to women. It develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. It products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness; with a broad collection of spherical, toric and multifocal contact lenses. The Company's customers are healthcare professionals and institutions providing care to and for women. Its products support the point of healthcare delivery in the hospital, clinician's office and fertility clinics. The Company's major manufacturing and distribution facilities are located in Trumbull, Connecticut, Malov, Denmark, Pasadena, California, Stafford, Texas, and Berlin, Germany. The Company's products are medical devices subject to extensive regulation by the United States Food and Drug Administration (FDA) in the United States and other regulatory bodies abroad. The Company's raw materials primarily consist of various chemicals and packaging materials and are generally available from more than one source. It markets its products in the United States through field sales representatives, who call on optometrists, ophthalmologists, opticians, optical chains and distributors.
» More Articles for COO

Headlines

Articles On GuruFocus.com
Steve Mandel Buys Visa, DaVita Healthcare In Q4 Feb 19 2015 
CooperVision MyDay(R) Daily Disposable Lenses Now Available in Hong Kong Jan 04 2015 
Offsetters Helps Vancity Credit Union Achieve Carbon Neutrality for 6th Consecutive Year Dec 19 2014 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Offsetters Climate Solutions Inc.: British Columbia Government Establishes New Regulated Carbon Offs Oct 23 2014 
Weekly CEO Sells Highlight: Cooper Companies, Broadcom Corp, Realpage Inc, and Freescale Semiconduct Jul 14 2014 
Baron Funds Comments on The Cooper Companies May 02 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Manning & Napier New Buys of Q1 Apr 19 2013 
The Cooper Companies: Not Eyeing It Yet Nov 27 2012 

More From Other Websites
Receptos Inc (RCPT), Centene Corp (CNC): Paul Sinclair Flying High With New Fund’s Top Healthcare... Apr 14 2015
Lone Pine Adds New Stake in The Cooper Companies Apr 14 2015
Insider Selling Slows as Earnings Season Begins Apr 11 2015
Lone Pine Capital Holdings Traded During 4Q14 Apr 10 2015
Cooper Companies (COO) Stock Slightly Lower Today Despite Increased Price Target Mar 31 2015
COOPER COMPANIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Mar 18 2015
The Cooper Companies Seeks License Option from EP Global - Analyst Blog Mar 17 2015
The Cooper Companies Holds Annual Meeting of Stockholders Mar 16 2015
CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately Mar 16 2015
COOPER COMPANIES INC Financials Mar 14 2015
The Cooper Companies Hits 52-Week High on Earnings Beat - Analyst Blog Mar 09 2015
The Cooper Companies Inc. (COO) Jumps: Stock Adds 9% - Tale of the Tape Mar 09 2015
What Analysts Are Saying About Cooper Companies Mar 07 2015
Cooper, Foot Locker Break Out To New Highs Mar 06 2015
COOPER COMPANIES INC Files SEC form 10-Q, Quarterly Report Mar 06 2015
The Cooper Companies Tops Q1 Earnings, Lags Revenues - Analyst Blog Mar 06 2015
What We're Trading Mar 06 2015
After-hours buzz: Gap, Finisar, Diamond & more Mar 05 2015
The Cooper Companies Announces First Quarter 2015 Results Mar 05 2015
COOPER COMPANIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 05 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK